Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 133, Issue 3, Pages 624-636
Publisher
Wiley
Online
2013-01-30
DOI
10.1002/ijc.28070
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
- (2012) Abhishek D Garg et al. EMBO JOURNAL
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
- (2011) Oliver Kepp et al. CANCER AND METASTASIS REVIEWS
- Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses
- (2011) Sofia R. Gameiro et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunological effects of Taxol and Adryamicin in breast cancer patients
- (2011) C. Panis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes
- (2011) Michael S. Leibowitz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prerequisites for the Antitumor Vaccine-Like Effect of Chemotherapy and Radiotherapy
- (2011) Dalil Hannani et al. CANCER JOURNAL
- Immune parameters affecting the efficacy of chemotherapeutic regimens
- (2011) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- Desirable cell death during anticancer chemotherapy
- (2010) Clara Locher et al. Annals of the New York Academy of Sciences
- Surface-exposed calreticulin in the interaction between dying cells and phagocytes
- (2010) Isabelle Martins et al. Annals of the New York Academy of Sciences
- Chemotherapy induces ATP release from tumor cells
- (2010) Isabelle Martins et al. CELL CYCLE
- Characteristics of CD133+ Human Colon Cancer SW620 Cells
- (2010) Hironobu Kawamoto et al. CELL TRANSPLANTATION
- Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
- (2010) L. Zitvogel et al. CLINICAL CANCER RESEARCH
- Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
- (2010) I Martins et al. ONCOGENE
- Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
- (2010) M. P. Chao et al. Science Translational Medicine
- Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma
- (2009) V. Racanelli et al. BLOOD
- Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer
- (2009) Barbara Seliger et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice
- (2009) Hironobu Minami et al. CANCER SCIENCE
- Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
- (2009) Theocharis Panaretakis et al. EMBO JOURNAL
- Calreticulin maintains the low threshold of peptide required for efficient antigen presentation
- (2009) Hongmei Fu et al. MOLECULAR IMMUNOLOGY
- Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors
- (2008) A. F. Setiadi et al. CANCER RESEARCH
- The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
- (2008) T Panaretakis et al. CELL DEATH AND DIFFERENTIATION
- Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity: Effects of Docetaxel on Immune Enhancement
- (2008) C. T. Garnett et al. CLINICAL CANCER RESEARCH
- Paradigm Shifts in Cancer Vaccine Therapy
- (2008) Jeffrey Schlom et al. EXPERIMENTAL BIOLOGY AND MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started